Circulite's blood pump succeeds in human trial
This article was originally published in Clinica
Top-line results from a trial of Synergy, CircuLite's circulatory assist device, have shown that it improves the quality of life of patients awaiting heart transplants.
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.